Poll Shows Psychedelics Support at Similar Level to Early Marijuana Reform Days

A new survey from the RAND Corporation shows that public support for legalizing psychedelics like psilocybin is sitting at 23%, which is remarkably similar to where marijuana stood back in the mid-90s before the green wave took off. While the general public is still a bit hesitant about broad legalization for LSD or MDMA, there is a clear appetite for medical access, with roughly 10 million Americans already microdosing to boost their mental well-being. Much like the early days of cannabis reform, those who have actually tried these substances are much more likely to back legalization.

For the cannabis community, this trend is exciting because it suggests we are witnessing the birth of a new movement that mirrors our own history. As more people realize the therapeutic potential of these plants and fungi, the push for regulated, safe access will likely explode just like it did for weed. This matters because it highlights a growing shift toward personal health freedom and could eventually lead to more diverse options for natural wellness right alongside our favorite flower.